Drug experts on the new guidance for medicinal cannabis

“NICE examined thousands of studies and found that most evidence on cannabis-based products for medicinal use was poor – much weaker than is often popularly discussed. The original decision to change the law on cannabis was led more by political than clinical considerations,” Ian Hamilton of University of York and Harry Sumnall of Liverpool John Moores University write.